Shenzhen YHLO Biotech Co., Ltd. (688575.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 9.69

From 52W high−14.50%

Volume10.12M

Market capCNY 5.26B

P/E (TTM)225.2x

P/S (TTM)3.1x

Div yield0.22%

Key dataSep 18, 2026

Open

CNY 9.69

From 52W high

−14.50%

Volume

10.12M

Market cap

CNY 5.26B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

14.4x

P/E (TTM)

225.2x

RSI (14)

50.0

MomentumView details →

1D Return

−3.66%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

225.2x

EV/EBITDA

14.4x

EV/Sales

3.3x

P/S (TTM)

3.1x

P/B (TTM)

1.9x

ProfitabilityView details →

Gross Margin

65.53%

Net Margin

1.74%

EBITDA Margin

22.78%

ROE (TTM)

1.15%

ROA (TTM)

0.72%

Asset Turnover

0.42x

GrowthView details →

Revenue YoY

−10.38%

EPS YoY

−86.22%

FCF YoY

+541.31%

Revenue CAGR 3Y

−23.10%

EPS CAGR 3Y

−71.83%

EBITDA YoY

—

MomentumView details →

1D Return

−3.66%

YTD Return

—

1Y Return

—

RSI (14)

50.0

vs 50D SMA

+1.99%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.34x

Current Ratio

2.19x

Quick Ratio

1.53x

Div Yield

0.22%

Div Rate

CNY 0.02

Div Growth 1Y

−90.00%

EarningsView details →

EPS (Actual)

CNY 0.09

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−1.09%

Financials snapshotView financials →

Revenue (TTM)

1.79B

Net Income (TTM)

31.14M

Op. CF (TTM)

506.11M

Next earningsOct 26, 2026 →

Latest newsMore news →

Yalun Biotechnology received medical device registration certificates from Guangdong Provincial Drug Administration for two microfluidic chemiluminescence immunoassay analyzers (iNexaLume-A and iNexaLume-B), valid until August 12, 2031.34d ago

Similar companies

普门科技688389.SH 翔宇医疗688626.SH 东方生物688298.SH 安旭生物688075.SH 健麾信息605186.SH 祥生医疗688358.SH Find similar companies →

Latest newsMore news →

Yalun Biotechnology received medical device registration certificates from Guangdong Provincial Drug Administration for two microfluidic chemiluminescence immunoassay analyzers (iNexaLume-A and iNexaLume-B), valid until August 12, 2031.34d ago